Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement
I'm PortAI, I can summarize articles.
FREEHOLD, N.J., June 27, 2025 ( GLOBE NEWSWIRE ) -- Channel Therapeutics Corporation, ( "Channel" or the "Company" ) , CHRO, an emerging leader in the development of non-opioid pain treatment therapeutics, today announced a 10-for-one reverse split ( the "Reverse Stock Split" ) of the Company's ...
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments